Molecular Mechanism of CCAAT-Enhancer Binding Protein Recruitment by the TRIB1 Pseudokinase

被引:80
|
作者
Murphy, James M. [1 ,2 ]
Nakatani, Yoshio [3 ]
Jamieson, Sam A. [4 ]
Dai, Weiwen [1 ,2 ]
Lucet, Isabelle S. [1 ,2 ]
Mace, Peter D. [4 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia
[3] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand
[4] Univ Otago, Otago Sch Med Sci, Dept Biochem, Dunedin 9054, New Zealand
基金
澳大利亚国家健康与医学研究理事会;
关键词
ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; C/EBP-ALPHA; CRYSTAL-STRUCTURE; TRIBBLES HOMOLOG; BIOLOGICAL MACROMOLECULES; INSULIN-RECEPTOR; GENE-EXPRESSION; KINASE DOMAIN; ACTIVATION;
D O I
10.1016/j.str.2015.08.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CCAAT-enhancer binding proteins (C/EBPs) are transcription factors that play a central role in the differentiation of myeloid cells and adipocytes. Tribbles pseudokinases govern levels of C/EBPs by recruiting them to the COP1 ubiquitin ligase for ubiquitination. Here, we present the first crystal structure of a Tribbles protein, which reveals a catalytically inactive TRIB1 pseudokinase domain with a unique adaptation in the alpha C helix. A second crystal structure and biophysical studies of TRIB1 with its C-terminal extension, which includes the COP1-binding motif, show that the C-terminal extension is sequestered at a site formed by the modified TRIB1 alpha C helix. In addition, we have identified and characterized the TRIB1 substrate-recognition sequence within C/EBP alpha, which is evolutionarily conserved in C/EBP transcription factors. Binding studies indicate that C/EBP alpha recruitment is weaker in the presence of the C-terminal COP1-binding motif, but the magnitude of this effect suggests that the two bind distinct rather directly overlapping binding sites.
引用
收藏
页码:2111 / 2121
页数:11
相关论文
共 50 条
  • [21] RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein α function
    Tokita, Katsuya
    Maki, Kazuhiro
    Mitani, Kinuko
    CANCER SCIENCE, 2007, 98 (11) : 1752 - 1757
  • [22] CCAAT-Enhancer Binding Protein-β Expression and Elevation in Alzheimer's Disease and Microglial Cell Cultures
    Strohmeyer, Ron
    Shelton, Jadd
    Lougheed, Christopher
    Breitkopf, Trisia
    PLOS ONE, 2014, 9 (01):
  • [23] Asthma and the CCAAT-enhancer binding proteins: A holistic view on airway inflammation and remodeling
    Borger, P
    Black, JL
    Roth, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (06) : 841 - 846
  • [24] PHOSPHORYLATION OF CCAAT-ENHANCER BINDING-PROTEIN BY PROTEIN-KINASE-C ATTENUATES SITE-SELECTIVE DNA-BINDING
    MAHONEY, CW
    SHUMAN, J
    MCKNIGHT, SL
    CHEN, HC
    HUANG, KP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (27) : 19396 - 19403
  • [25] The pseudokinase TRIB1 toggles an intramolecular switch to regulate COP1 nuclear export
    Kung, Jennifer E.
    Jura, Natalia
    EMBO JOURNAL, 2019, 38 (04):
  • [26] Expression of the genes encoding CCAAT-enhancer binding protein isoforms in the mouse mammary gland during lactation and involution
    Sabatakos, G.
    Davies, G.E.
    Grosse, M.
    Cryer, A.
    Ramji, D.P.
    Biochemical Journal, 1998, 334 (pt 1): : 205 - 210
  • [27] Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems
    Burul-Bozkurt, N.
    Cincioglu, M.
    Kelicen, P.
    Pekiner, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 91 - 91
  • [28] Expression of the genes encoding CCAAT-enhancer binding protein isoforms in the mouse mammary gland during lactation and involution
    Sabatakos, G
    Davies, GE
    Grosse, M
    Cryer, A
    Ramji, DP
    BIOCHEMICAL JOURNAL, 1998, 334 : 205 - 210
  • [29] Enhancement of host defense gene expression by glucocorticoids (GC) is mediated by CCAAT-enhancer binding protein (C/EBP)
    Zhang, N
    Troung-Tran, AQ
    Tancowny, B
    Schleimer, RP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S16 - S16
  • [30] Uncovering the mechanism of Trib1 in cancer immunotherapy.
    Iheanacho, Franklin
    Stein, Sarah J.
    Rome, Kelly S.
    Jordan, Martha S.
    Pear, Warren S.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 59 - 59